Plasma nucleoside and base levels following treatment with the new thymidylate synthetase inhibitor CB 3717.
D000818:Animals; D005492:Folic Acid / Q000031:analogs & derivatives*; D005493:Folic Acid Antagonists / Q000633:toxicity*; D007700:Kinetics; D007939:Leukemia L1210 / Q000097:blood*; D008780:Methyltransferases / Q000037:antagonists & inhibitors*; D051379:Mice; D008815:Mice, Inbred Strains; D009705:Nucleosides / Q000097:blood*; D011687:Purines / Q000097:blood; D011743:Pyrimidines / Q000097:blood; D011799:Quinazolines / Q000633:toxicity*; D013940:Thymidylate Synthase / Q000037:antagonists & inhibitors*
D005493:Folic Acid Antagonists; D009705:Nucleosides; D011687:Purines; D011743:Pyrimidines; D011799:Quinazolines; C031662:CB 3717; D005492:Folic Acid; D008780:Methyltransferases; D013940:Thymidylate Synthase